New York Life Trust’s ResMed RMD Stock Holding History

New York Life Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-425	Closed	-$28K	–	245
2016 Q3	$28K	Sell	425 -699	-62%	-$46.5K	0.14%	164
2016 Q2	$71K	Buy	+1,124	New	+$66.3K	0.34%	104

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

New York Life Trust's RMD Position: Q4 2016 in Review

New York Life Trust sold out of ResMed (RMD) in Q4 2016, closing a stake of 425 shares — an estimated $28K sold.

New York Life Trust first reported a position in RMD in Q2 2016 and held it in 2 quarters. The position peaked at $71K in Q2 2016. 362 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

New York Life Trust reported no remaining ResMed position as of Q4 2016 after selling out during the quarter.
New York Life Trust sold 425 ResMed shares in Q4 2016, an estimated $28K.
New York Life Trust first reported a position in ResMed in Q2 2016 and held it in 2 quarters.
New York Life Trust's ResMed position peaked at $71K in Q2 2016.
362 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on New York Life Trust's 13F filing for Q4 2016, filed 15 Feb 2017.